Hepatic steatosis is associated with greater noncalcified plaque burden (NCPB) and an increased risk for a MACE.

A clinical trial of more than 3,600 patients evaluated for chest pain showed that fatty liver disease was linked to nearly ...

Please provide your email address to receive an email when new articles are posted on . Hepatic steatosis was detected among 50.2% of adults younger than 45 years without history of MASLD. Rates of ...

Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives disease progression to intrahepatic conditions such as ...

Please provide your email address to receive an email when new articles are posted on . More than half of patients with baseline fatty liver disease experienced a reduction in hepatic steatosis after ...

A nationwide, population-based cohort study of patients with imaging-confirmed hepatic steatosis assessed the long-term risks associated with three distinct steatotic liver disease subtypes. Liver and ...

National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that ...

Researchers at Mass General Brigham Heart and Vascular Institute found that people with hepatic steatosis, commonly called "fatty liver disease," have a higher amount of noncalcified, rupture-prone ...

Liver steatosis is more prevalent than liver fibrosis in people with HIV, with significant risk factors including age, hypertension, and diabetes. Liver fibrosis prevalence is low, with integrase ...